Clinical Trials Browser

Phase 1/2 × Pyruvic Acid × Clear all

NCT02913131 2022-04-22

Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies

Phase 1/2 Terminated

23 enrolled 6 charts

Prostatic Neoplasms